Norges Bank Horizon Therapeutics Public LTD CO Transaction History

Norges Bank

  • $655 Billion
  • Q2 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$98.98 - $115.74 $230 Million - $269 Million
-2,321,956 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$96.34 - $112.38 $535 Million - $625 Million
5,557,306 New
5,557,306 $572 Million
Q2 2023

Aug 14, 2023
SELL
$96.34 - $112.38 $210 Million - $246 Million
-2,184,692 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$107.32 - $113.5 $452 Million - $479 Million
4,216,126 New
4,216,126 $460 Million
Q4 2022

Feb 14, 2023
BUY
$62.39 - $113.8 $137 Million - $250 Million
2,194,888 New
2,194,888 $250 Million
Q3 2022

Nov 13, 2023
BUY
$58.92 - $84.67 $137 Million - $197 Million
2,321,956 New
2,321,956 $144 Million
Q2 2022

Aug 14, 2023
BUY
$79.4 - $116.36 $173 Million - $254 Million
2,184,692 New
2,184,692 $174 Million
Q1 2022

May 12, 2023
BUY
$86.42 - $109.81 $14.9 Million - $19 Million
172,761 Added 7.87%
2,367,649 $249 Million
Q1 2022

May 09, 2022
SELL
$86.42 - $109.81 $201 Million - $255 Million
-2,324,851 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$98.56 - $119.91 $229 Million - $279 Million
2,324,851 New
2,324,851 $251 Million
Q3 2021

Nov 14, 2022
BUY
$91.91 - $110.37 $195 Million - $234 Million
2,118,669 New
2,118,669 $232 Million
Q3 2021

Nov 05, 2021
SELL
$91.91 - $110.37 $191 Million - $229 Million
-2,078,973 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$86.24 - $95.92 $179 Million - $199 Million
2,078,973 New
2,078,973 $195 Million
Q2 2021

Aug 10, 2021
SELL
$86.24 - $95.92 $161 Million - $179 Million
-1,870,774 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$71.83 - $95.48 $134 Million - $179 Million
1,870,774 New
1,870,774 $172 Million
Q1 2021

May 07, 2021
SELL
$71.83 - $95.48 $121 Million - $161 Million
-1,681,337 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$67.0 - $84.39 $113 Million - $142 Million
1,681,337 New
1,681,337 $123 Million
Q4 2020

Feb 10, 2021
SELL
$67.0 - $84.39 $123 Million - $155 Million
-1,840,392 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$55.23 - $79.93 $102 Million - $147 Million
1,840,392 New
1,840,392 $143 Million
Q3 2020

Nov 10, 2020
SELL
$55.23 - $79.93 $104 Million - $151 Million
-1,889,660 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$30.2 - $56.98 $57.1 Million - $108 Million
1,889,660 New
1,889,660 $105 Million
Q2 2020

Aug 07, 2020
SELL
$30.2 - $56.98 $63.5 Million - $120 Million
-2,104,185 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$24.87 - $38.56 $52.3 Million - $81.1 Million
2,104,185 New
2,104,185 $62.3 Million
Q1 2020

May 08, 2020
SELL
$24.87 - $38.56 $52.2 Million - $80.9 Million
-2,098,191 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$25.43 - $36.67 $53.4 Million - $76.9 Million
2,098,191 New
2,098,191 $76 Million
Q4 2019

Feb 12, 2020
SELL
$25.43 - $36.67 $56.1 Million - $80.9 Million
-2,205,904 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$23.0 - $27.97 $50.7 Million - $61.7 Million
2,205,904 New
2,205,904 $60.1 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email